4.7 Article

Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy

Journal

MOLECULAR CANCER
Volume 8, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1476-4598-8-2

Keywords

-

Funding

  1. FMMA
  2. Spanish Department of Education and Science [SAF2006-04755]
  3. UTE project CIMA

Ask authors/readers for more resources

Background: Bioluminescent imaging (BLI) is based on the detection of light emitted by living cells expressing a luciferase gene. Stable transfection of luciferase in cancer cells and their inoculation into permissive animals allows the noninvasive monitorization of tumor progression inside internal organs. We have applied this technology for the development of a murine model of colorectal cancer involving the liver, with the aim of improving the pre-clinical evaluation of new anticancer therapies. Results: A murine colon cancer cell line stably transfected with the luciferase gene (MC38Luc1) retains tumorigenicity in immunocompetent C57BL/6 animals. Intrahepatic inoculation of MC38Luc1 causes progressive liver infiltration that can be monitored by BLI. Compared with ultrasonography (US), BLI is more sensitive, but accurate estimation of tumor mass is impaired in advanced stages. We applied BLI to evaluate the efficacy of an immunogene therapy approach based on the liver-specific expression of the proinflammatory cytokine interleukin-12 (IL-12). Individualized quantification of light emission was able to determine the extent and duration of antitumor responses and to predict long-term disease-free survival. Conclusion: We show that BLI is a rapid, convenient and safe technique for the individual monitorization of tumor progression in the liver. Evaluation of experimental treatments with complex mechanisms of action such as immunotherapy is possible using this technology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability

Beatriz Pacin-Ruiz, Maria Francesca Cortese, David Tabernero, Sara Sopena, Josep Gregori, Selene Garcia-Garcia, Rosario Casillas, Adrian Najarro, Unai Aldama, Adriana Palom, Ariadna Rando-Segura, Anna Galan, Marta Vila, Mar Riveiro-Barciela, Josep Quer, Gloria Gonzalez-Aseguinolaza, Maria Buti, Francisco Rodriguez-Frias

Summary: This study used next-generation sequencing to analyze the ribozyme quasispecies of hepatitis delta virus (HDV). The ribozyme was found to be highly conserved overall, with a hyper-conserved region between nucleotides 715-745. Several mutations were observed, with the deletion of C64 showing a strong impact on HDV replication. The findings suggest that the conserved region of the ribozyme could be a potential target for gene-silencing strategies.

VIRUSES-BASEL (2022)

Article Oncology

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

Borja Ruiz-Fernandez de Cordoba, Haritz Moreno, Karmele Valencia, Naiara Perurena, Pablo Ruedas, Thomas Walle, Alberto Pezonaga-Torres, Juan Hinojosa, Elisabet Guruceaga, Antonio Pineda-Lucena, Marta Abengozar-Muela, Denis Cochonneau, Carolina Zandueta, Susana Martinez-Canarias, Alvaro Teijeira, Daniel Ajona, Sergio Ortiz-Espinosa, Xabier Morales, Carlos Ortiz de Solorzano, Marta Santisteban, Luis Ramos-Garcia, Laura Guembe, Vratislav Strnad, Dominique Heymann, Sandra Hervas-Stubbs, Ruben Pio, Maria E. Rodriguez-Ruiz, Carlos E. de Andrea, Silvestre Vicent, Ignacio Melero, Fernando Lecanda, Rafael Martinez-Monge

Summary: Locoregional failure in breast cancer patients after surgery and irradiation is linked to a poor prognosis. The ENPP1/HP axis is exploited by tumor cells to promote local recurrence by suppressing immune cells. Blocking this axis offers new opportunities for therapeutic intervention.

CANCER DISCOVERY (2022)

Article Biochemistry & Molecular Biology

Muscular and Tendon Degeneration after Achilles Rupture: New Insights into Future Repair Strategies

Lara Gil-Melgosa, Jorge Grasa, Ainhoa Urbiola, Rafael Llombart, Miguel Susaeta Ruiz, Veronica Montiel, Cristina Ederra, Begona Calvo, Mikel Ariz, Purificacion Ripalda-Cemborain, Felipe Prosper, Carlos Ortiz-de-Solorzano, Juan Pons-Villanueva, Ana Perez Ruiz

Summary: This study investigates the morphological changes in the tendon, the myotendinous junction, and muscle belly after Achilles tendon rupture in a mouse model. The findings reveal cellular and fatty infiltration, fibrotic tissue accumulation, muscle stem cell decline, and collagen fiber disorganization, which contribute to the loss of muscle mechanical function. This research is important for improving regenerative medicine practices for Achilles tendon ruptures.

BIOMEDICINES (2022)

Article Oncology

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Sergio Ortiz-Espinosa, Xabier Morales, Yaiza Senent, Diego Alignani, Beatriz Tavira, Irati Macaya, Borja Ruiz, Haritz Moreno, Ana Remirez, Cristina Sainz, Alejandro Rodriguez-Pena, Alvaro Oyarbide, Mikel Ariz, Maria P. Andueza, Karmele Valencia, Alvaro Teijeira, Kai Hoehlig, Axel Vater, Barbara Rolfe, Trent M. Woodruff, Jose Maria Lopez-Picazo, Silvestre Vicent, Grazyna Kochan, David Escors, Ignacio Gil-Bazo, Jose Luis Perez-Gracia, Luis M. Montuenga, John D. Lambris, Carlos Ortiz de Solorzano, Fernando Lecanda, Daniel Ajona, Ruben Pio

Summary: This study reveals that C5a can enhance the capacity of PMN-MDSCs to promote tumor growth and metastasis by inducing the formation of NETs. The formation of NETs is dependent on the production of HMGB1 by cancer cells. Inhibiting C5a, C5aR1, or NETosis can reduce the number of circulating tumor cells and the metastatic burden in a mouse lung metastasis model. The translational relevance of these findings is supported by the stimulation of migration and NETosis in PMN-MDSCs obtained from lung cancer patients.

CANCER LETTERS (2022)

Article Computer Science, Artificial Intelligence

NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images

Daniel Jimenez-Sanchez, Mikel Ariz, Hang Chang, Xavier Matias-Guiu, Carlos E. de Andrea, Carlos Ortiz-de-Solorzano

Summary: NaroNet is a deep learning framework that models the multi-scale tumor microenvironment from multiplex-stained cancer tissue images and provides patient-level interpretable predictions. The model learns the influence of cell phenotypes, cell neighborhoods, and neighborhood interactions on predicting the correct label through unsupervised learning.

MEDICAL IMAGE ANALYSIS (2022)

Article Biochemical Research Methods

Application of a split-Cre system for high-capacity adenoviral vector amplification

Manuela Gonzalez-Aparicio, Maria Bunuales, Inaki Ortiz de Landazuri, Jesus Prieto, Ruben Hernandez-Alcoceba

Summary: This study improves the performance of packaging cells and increases the production efficiency of high-capacity adenoviral vectors (HC-AdV) by using a dimerizable Cre system. It also reduces the time and cost of HC-AdV production, contributing to the standardization of HC-AdV production.

BIOTECHNOLOGY JOURNAL (2023)

Article Biochemistry & Molecular Biology

Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice

Andrea Bazo, Aquilino Lantero, Itsaso Mauleon, Leire Neri, Martin Poms, Johannes Haberle, Ana Ricobaraza, Bernard Benichou, Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza, Rafael Aldabe

Summary: This study evaluated the therapeutic efficacy of gene therapy for treating Citrullinemia type I (CTLN1). The results showed that this treatment method can improve the condition and increase the survival rate of patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Gastroenterology & Hepatology

Gene therapy for liver diseases - progress and challenges

Nerea Zabaleta, Carmen Unzu, Nicholas D. Weber, Gloria Gonzalez-Aseguinolaza

Summary: In this review, the authors discuss gene therapy involving the use of recombinant adeno-associated virus vectors for the treatment of inherited liver diseases, including ongoing clinical trials that are producing promising results. Clinical testing has revealed several key challenges associated with gene therapy, such as the interaction of the immune system with the vector and the risk of adverse events. The permanent modification of the host genome through gene editing raises concerns about oncogenicity and requires careful evaluation.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy

Nicholas D. Weber, Leticia Odriozola, Irene Ros-Ganan, Guillermo Garcia-Porrero, David Salas, Josepmaria Argemi, Jean-Philippe Combal, Takashi K. Kishimoto, Gloria Gonzalez-Aseguinolaza

Summary: The study demonstrates that repeat administration of rAAV combined with immunotolerant nanoparticles can effectively treat PFIC3 in infant mice and reduce the risk of liver cancer.

JHEP REPORTS (2023)

Review Biotechnology & Applied Microbiology

Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors

Helena Costa-Verdera, Carmen Unzu, Erika Valeri, Sahil Adriouch, Gloria Gonzalez Aseguinolaza, Federico Mingozzi, Anna Kajaste-Rudnitski

Summary: As the clinical experience in AAV vector-based gene therapies grows, there is a need to better understand and control the host immune responses. Our current understanding of the immune responses to AAV gene therapies is limited, which is further hindered by the lack of replication of clinical findings in preclinical animal models.

HUMAN GENE THERAPY (2023)

Article Computer Science, Interdisciplinary Applications

Synplex: In Silico Modeling of the Tumor Microenvironment From Multiplex Images

Daniel Jimenez-Sanchez, Mikel Ariz, Carlos E. De Andrea, Carlos Ortiz-De-Solorzano

Summary: Multiplex immunofluorescence is a highly relevant imaging technique for studying the tumor microenvironment and discovering disease biomarkers. The analysis of these images requires the use of machine learning tools and the availability of large image datasets. This study presents Synplex, a computer simulator that generates multiplexed immunofluorescence images based on user-defined parameters.

IEEE TRANSACTIONS ON MEDICAL IMAGING (2023)

Article Cell Biology

Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress

Susana Aguilar, Paula Garcia-Olloqui, Lidia Amigo-Moran, Jose Luis Toran, Juan Antonio Lopez, Guillermo Albericio, Gloria Abizanda, Diego Herrero, Africa Vales, Saray Rodriguez-Diaz, Marina Higuera, Ruben Garcia-Martin, Jesus Vazquez, Carmen Mora, Gloria Gonzalez-Aseguinolaza, Felipe Prosper, Beatriz Pelacho, Antonio Bernad

Summary: Oxidative stress-induced myocardial apoptosis and necrosis play a critical role in ischemic infarction. This study identified and validated miR-935 as a highly differentially expressed miRNA in exosomes derived from human cardiac progenitor cells (CPC). Reduction of miR-935 expression promotes oxidative stress-associated apoptosis. Together with other exosomal miRNA members, miR-935 may counteract oxidative stress-related apoptosis in the CPC microenvironment.

CELLS (2023)

Article Pharmacology & Pharmacy

Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells

Andoni Gomez-Moreno, Enara San Sebastian, Jennifer Moya, Pilar Gomollon-Zueco, Sergio Isola, Africa Vales, Gloria Gonzalez-Aseguinolaza, Carmen Unzu, Urtzi Garaigorta

Summary: Gene therapy is a promising approach to treat inherited metabolic liver disorders. This study shows that using topoisomerase inhibitors can increase the expression of viral genes in non-dividing hepatic cells, with a greater effect seen in the integration-deficient LV strain. These effects are associated with increased DNA damage response.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

The potential of bioprinting for preparation of nanoparticle-based calibration standards for LA-ICP-ToF-MS quantitative imaging

Kharmen Billimoria, Yuri A. Diaz Fernandez, Elina Andresen, Ioritz Sorzabal-Bellido, Gonzalo Huelga-Suarez, Dorota Bartczak, Carlos Ortiz de Solorzano, Ute Resch-Genger, Heidi Goenaga Infante

Summary: This paper discusses the feasibility of a novel strategy based on the combination of bioprinting nano-doping technology and laser ablation-inductively coupled plasma time-of-flight mass spectrometry analysis for the preparation and characterization of gelatin-based multi-element calibration standards suitable for quantitative imaging. The results show that bioprinting method has better between batch repeatability and elemental signal homogeneity compared to traditional cryosectioning method. Additionally, the bioprinting method can significantly reduce the preparation time of standards and the bio-printed calibration standards are stable for a long period of time.

METALLOMICS (2022)

Article Immunology

Optimising the IgG-degrading enzyme treatment regimen for enhanced adeno-associated virus transduction in the presence of neutralising antibodies

Irene Ros-Ganan, Mirja Hommel, Laia Trigueros-Motos, Blanche Tamarit, Estefania Rodriguez-Garcia, David Salas, Guiomar Perez, Anne Douar, Jean Philippe Combal, Bernard Benichou, Veronica Ferrer, Gloria Gonzalez-Aseguinolaza

Summary: This study tested the effectiveness of an enzyme called IdeS in cleaving neutralizing antibodies and improving the transduction efficiency of AAV-mediated gene therapy. The results showed that IdeS was able to efficiently cleave human IgG and had varying effects on different AAV serotypes in vivo. The study suggests that preconditioning with IdeS could provide a unique treatment opportunity for patients who are excluded from gene therapy due to elevated levels of anti-AAV antibodies.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

No Data Available